Date: 2021
Citation: Nguyen AD, Baysari MT, Duong M, Zheng WY, Ng B, Lo S, Robinson F, Hilmer SN. Communicating deprescribing decisions made in hospital with general practitioners in the community: a qualitative study. Internal Medicine Journal. 2021 Jan 19.
Date: 2021
Citation: Weir, Kristie Rebecca, et al. “The role of older patients’ goals in GP decision-making about medicines: a qualitative study.” BMC Family Practice 22.1 (2021): 1-12.
Date: 2019
Citation: Ailabouni, N., Mangin, D. & Nishtala, P.S. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm 41, 167–178 (2019)
Date: 2019
Citation: Weir, Kristie Rebecca, et al. “Pharmacists and patients sharing decisions about medicines: Development and feasibility of a conversation guide.” Research in Social and Administrative Pharmacy 15.6 (2019): 682-690.
Date: 2017
Citation: Reeve, Emily, Wade Thompson, and Barbara Farrell. “Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.” European Journal of Internal Medicine 38 (2017): 3-11.